Sarcoidosis of this disease is a m...

Sarcoidosis of this disease is a multisystem granulomatous disease of unknown etiology that predominantly affects the lung The many forms and presentations and the lack of a single diagnostic trial can make the diagnosis challenging. Physicians have limited guidance for the treatment of sarcoidosis because of a lack of high-quality randomized controll trials (RCTs) This article reviews the epidemiology, etiology, clinical presentation, diagnosis, and now passing evidence on the treatment of pulmonary and extrapulmonary sarcoidosis.

Epidemiology

Sarcoidosis affects men and women of all races and ages. The condition usually at hands in adults younger than 40 years, in the greatest degree frequently between 20 and 29 years of age. It is slightly more predominant in women than in men with an incidence of 63 and 59 cases by 100,000 person-years, respectively. The lifetime risk of sarcoidosis for U whites is estimated at 085 percent compared with 24 percent in U blacks. Sarcoidosis is greatest in number prevalent in Swedes, Danes, and U blacks. Mortality from sarcoidosis, usually caused on respiratory failure, approaches 1 to 5 percent (12) Because principally patients with sarcoidosis do not die of the disease, the medical challenge is to help them live well with their symptoms.

Etiology and Pathogenesis

Multiple causes of sarcoidosis have been propos Evidence exists to support genetic inheritance, infectious transmission, and shared prospect to environmental agents. (3) Infectious organisms in the same state [i]or[/i] condition as viruses, mycobacteria, Borrelia burgdorferi, and Propionibacterium acnes have been implicated as potential causes of sarcoidosis. (1) Environmental aspect to beryllium, aluminum, and zirconium can originate in a granulomatous response similar to that of sarcoidosis. (1) general theory suggests that disease unfolds in genetically predetermined hosts who are expos to certain environmental agents that trigger an exaggerated inflammatory immune rejoinder leading to granuloma formation. (12)

The characteristic lesion of sarcoidosis is a discrete, noncaseating, epithelioid granuloma. The early sarcoid reaction flash on the minds when activated T cells and macrophages accumulate at sites of ongoing inflammation. These activated solitary abode; squalids release chemoattractants and growth factors that outcome in cellular proliferation and granuloma formation. Sarcoid granulomas decipher or leave behind fibrotic changes. The factors leading to fibrosis are poorly understood. (1)

Clinical Presentation and Organ Involvement

The clinical presentation of sarcoidosis hangs on ethnicity, duration of illness, site and length of organ involvement, and activity of the granulomatous proces The usual modifications of presentation include non-specific constitutional symptoms or symptoms related to organ-specific involvement. (2) Thirty to 50 percent of patients are asymptomatic and are diagnosed onward routine chest radiographs. One third of patients have non-specific symptoms of febrile affection fatigue, weight loss, and malaise. This presentation is more customary in blacks and Asian Indians. (1)

Acute sarcoidosis is more public in whites than in blacks and usually is associated with spontaneous remission within pair years. Spontaneous remission also meet the eyes in patients with Lofgren's syndrome which consists of bilateral hilar lymphadenopathy, ankle arthritis, erythema nodosum, flush myalgia, and weight loss. (1) Chronic sarcoidosis not absents insidiously with symptoms related to the organ involved, of that kind as cough and dyspnea from pulmonary infiltration. Chronic sarcoidosis commonly tread close upons a relapsing and protracted time course. (2) Chronic progressive disease affects 10 to 30 percent of patients. Spontaneous remission arises in approximately two thirds of these patients. Blacks have increased rates of pulmonary involvement, a worse long-term prognosis, and more usual relapses. (1)

The lung are involved in more than 90 percent of patients, with sarcoid usually presenting as interstitial disease. Symptoms are free from moisture cough, dyspnea, and chest discomfort. Pulmonary sarcoidosis has an unpredictable course that may proceed in spontaneous remission or lead to progressive los of lung function with fibrosis. There are four stages of pulmonary sarcoidosis (Table 1 (2) and Figure 1) Patients with stage I or II disease may have no symptoms, whereas stages III and IV can be characterized on progressive dyspnea, loss of lung function, and fibrosis. Airway involvement can befall and may result in airflow limitation, persistent cough and, in plain cases, bronchiectasis. Spontaneous remission can be awaited in 55 to 90 percent of patients with stage I disease, 40 to 70 percent with stage II disease, 10 to 20 percent with stage III disease, and nothing to 5 percent with stage IV disease. (12)

Sarcoidosis can involve multiple organs and cause a variety of clinical symptoms (Table 2) (12) Although granulomas are rest in 50 to 80 percent of liver biopsies, they rarely ensue in clinically significant hepatic dysfunction and usually cause single mild abnormalities in liver function ordeal results.